Literature DB >> 35573497

Fertility-Preserving Surgery of Borderline Serous Ovarian Tumors: A Case Report.

Ipsita Mohapatra1, Subha R Samantaray1, Nikku Harshini2.   

Abstract

Borderline ovarian tumors (BOTs) are tumors with low malignant potential and have an excellent prognosis. They are distinct by an epidemiological shift toward younger women. Fertility-sparing surgery is considered the gold standard in young patients presenting with BOTs. Spontaneous conception has been reported after conservative surgery with no enhanced risk of mortality or morbidity from disease progression during pregnancy. The prognosis of BOTs is very good; however, a small proportion of these tumors may recur and show malignant transformation. Timely follow-up of the patients is required for timely detection of any recurrence. We are presenting here a case of a 23-year-old woman diagnosed with BOT. The patient was nulliparous and hence was the appropriate candidate for fertility-sparing surgery. She underwent unilateral salpingo-oophorectomy and is now on regular follow-up.
Copyright © 2022, Mohapatra et al.

Entities:  

Keywords:  borderline ovarian tumors; conservative surgery; fertility sparing surgery; recurrence; younger women

Year:  2022        PMID: 35573497      PMCID: PMC9106565          DOI: 10.7759/cureus.24128

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  19 in total

1.  Oncologic and reproductive outcomes of cystectomy compared with oophorectomy as a treatment for borderline ovarian tumours.

Authors:  Taejong Song; Chel Hun Choi; Yoo-Young Lee; Tae-Joong Kim; Jeong-Won Lee; Duk-Soo Bae; Byoung-Gie Kim
Journal:  Hum Reprod       Date:  2011-04-21       Impact factor: 6.918

2.  Trends in the incidence of ovarian cancer and borderline tumours in Norway, 1954-1993.

Authors:  T Bjørge; A Engeland; S Hansen; C G Tropé
Journal:  Int J Cancer       Date:  1997-05-29       Impact factor: 7.396

Review 3.  Diagnosis, treatment, and follow-up of borderline ovarian tumors.

Authors:  Daniela Fischerova; Michal Zikan; Pavel Dundr; David Cibula
Journal:  Oncologist       Date:  2012-09-28

4.  Subjective assessment by ultrasound is superior to the risk of malignancy index (RMI) or the risk of ovarian malignancy algorithm (ROMA) in discriminating benign from malignant adnexal masses.

Authors:  Toon Van Gorp; Joan Veldman; Ben Van Calster; Isabelle Cadron; Karin Leunen; Frederic Amant; Dirk Timmerman; Ignace Vergote
Journal:  Eur J Cancer       Date:  2012-01-05       Impact factor: 9.162

5.  How to follow up advanced-stage borderline tumours? Mode of diagnosis of recurrence in a large series stage II-III serous borderline tumours of the ovary.

Authors:  C Uzan; A Kane; A Rey; S Gouy; P Pautier; C Lhomme; P Duvillard; P Morice
Journal:  Ann Oncol       Date:  2010-08-16       Impact factor: 32.976

6.  Borderline tumours of the ovary: A cohort study of the Arbeitsgmeinschaft Gynäkologische Onkologie (AGO) Study Group.

Authors:  Andreas du Bois; Nina Ewald-Riegler; Nikolaus de Gregorio; Alexander Reuss; Sven Mahner; Christina Fotopoulou; Friedrich Kommoss; Barbara Schmalfeldt; Felix Hilpert; Tanja Fehm; Alexander Burges; Werner Meier; Peter Hillemanns; Lars Hanker; Annette Hasenburg; Hans-Georg Strauss; Martin Hellriegel; Pauline Wimberger; Mignon-Denise Keyver-Paik; Klaus Baumann; Ulrich Canzler; Kerstin Wollschlaeger; Dirk Forner; Jacobus Pfisterer; Willibald Schröder; Karsten Münstedt; Barbara Richter; Stefan Kommoss; Steffen Hauptmann
Journal:  Eur J Cancer       Date:  2013-03-13       Impact factor: 9.162

7.  Borderline ovarian tumors in Sweden 1960-2005: trends in incidence and age at diagnosis compared to ovarian cancer.

Authors:  Ingiridur Skírnisdóttir; Hans Garmo; Erik Wilander; Lars Holmberg
Journal:  Int J Cancer       Date:  2008-10-15       Impact factor: 7.396

Review 8.  Diagnosis and treatment of borderline ovarian neoplasms "the state of the art".

Authors:  C Tropé; B Davidson; T Paulsen; V M Abeler; J Kaern
Journal:  Eur J Gynaecol Oncol       Date:  2009       Impact factor: 0.196

9.  Survival among women with borderline ovarian tumors and ovarian carcinoma: a population-based analysis.

Authors:  Mark E Sherman; Pamela J Mink; Rochelle Curtis; Timothy R Cote; Sandra Brooks; Patricia Hartge; Susan Devesa
Journal:  Cancer       Date:  2004-03-01       Impact factor: 6.860

10.  Risk of borderline and invasive ovarian tumours after ovarian stimulation for in vitro fertilization in a large Dutch cohort.

Authors:  F E van Leeuwen; H Klip; T M Mooij; A M G van de Swaluw; C B Lambalk; M Kortman; J S E Laven; C A M Jansen; F M Helmerhorst; B J Cohlen; W N P Willemsen; J M J Smeenk; A H M Simons; F van der Veen; J L H Evers; P A van Dop; N S Macklon; C W Burger
Journal:  Hum Reprod       Date:  2011-10-26       Impact factor: 6.918

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.